Advance Research

Advance Research

We are working to drive research to better treatments, and ultimately a cure, as quickly as possible

From basic science to clinical trial designs, the National Brain Tumor Society partners with the world’s leaders in research, public policy, and clinical care to advance the understanding of brain tumors, expand the availability of new treatments, and drive the discovery of a cure. With targeted programs for both adult and pediatric brain tumors, as well as other strategic initiatives to improve access and approvals of newfound discoveries, we drive bold, innovative programs to ensure a brighter future.

Integrated Initiatives

Integrated Initiatives

Uniquely poised to drive change and progress throughout the drug discovery and development pipeline, our initiatives and programs further knowledge and deliver results to our community.

Our funding strategy

Our Funding Strategy

Driven by the needs of this community, we have funded more than $30 million dollars of promising and innovative research for both adults and pediatric brain tumors.

Research funding opportunities

Funding Opportunities

Our innovative funding models are designed to support rigorous scientific investigation and drive progress toward treatments and the discovery of a cure.

From the Blog

  • November 19, 2015

    Tsunami: Trial of a brain tumor


    Arthur Weinfeld’s vision was in decline. His right eye had become blurry, which made focusing on a sheet of music difficult. At 77, he assumed it was a cataract. With little del

    Read More

  • November 18, 2015

    GBM AGILE: A Community Galvanized


    “GBM is just unacceptable…we no longer accept the status quo.” – Dr. Anna Barker Last week, you likely took notice of the press release, guest blog from Dr. Anna Barker, and a flurry of social media activity related to the announcement of

    Read More

  • November 6, 2015

    Survey Results: Brain Tumor Treatment & Diagnosis

    July 22, 2010

    Remember back in the summer of 2014 when we asked you to fill out our Patient and Caregiver Survey? Well we sure do, as your participation in this survey has provided not only us, but also the FDA, researchers, clinician, and drug makers

    Read More

More from the blog